Opportunity Information: Apply for RFA CA 23 031
This NIH funding opportunity (RFA-CA-23-031) supports a cooperative agreement (U24, clinical trial not allowed) to establish and run a Data Management and Coordinating Unit for a precompetitive collaboration focused on liquid biopsy approaches for early cancer assessment. It sits within the broader mission of the National Cancer Institute's Early Detection Research Network (EDRN), which is built to discover, develop, and validate biomarkers and imaging methods that can detect cancers at earlier, more treatable stages and then move those advances toward clinical testing. The EDRN is positioned as a mature, multicenter infrastructure, and the notice highlights that it has already completed more than 10 multicenter validation studies, underscoring that this is meant to support coordinated, network-scale research rather than isolated projects.
The core purpose of the award is to provide the coordinating backbone for collaborative, precompetitive work in liquid biopsy, meaning the emphasis is on shared resources, standardized data practices, and cross-institution coordination that can benefit the field broadly rather than proprietary development. As a Data Management and Coordinating Unit, the funded group would be expected to manage and harmonize data flows across participating sites or projects, support consistent study operations and communications, and help ensure that datasets and associated documentation are organized in a way that enables rigorous evaluation, comparison, and eventual validation. Because the mechanism is a cooperative agreement, NIH/NCI program staff typically play an active role in oversight and coordination, with substantial federal involvement in guiding goals, milestones, and network integration.
The opportunity is categorized under health and education-related federal assistance and is associated with CFDA 93.394. The award ceiling listed is $450,000, and the original closing date shown is May 5, 2023, indicating this particular solicitation was time-bound to that cycle. The "clinical trial not allowed" designation means applicants are not permitted to propose a clinical trial as defined by NIH; the work should instead focus on coordination, data management, infrastructure, and other non-trial activities that enable or support the broader research enterprise.
Eligibility is broad and includes many types of U.S.-based organizations: state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing/Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in that specific classification); for-profit organizations other than small businesses; small businesses; and other eligible entities. The notice also explicitly calls out additional eligible applicant categories often emphasized in NIH funding, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized entities (as applicable), and U.S. territories or possessions.
Foreign participation is specifically restricted. While the list mentions "Non-domestic (non-U.S.) Entities (Foreign Organizations)" in the context of "other eligible applicants," the eligibility section then clearly states that non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, non-domestic components of U.S. organizations are not eligible to apply, and foreign components as defined by the NIH Grants Policy Statement are not allowed. In practice, that means the applicant organization must be domestic, and the project cannot include foreign components under NIH's definitions.
Overall, this solicitation is best understood as support for the operational and data coordination hub needed to make multi-site, multi-team liquid biopsy efforts comparable, reproducible, and validation-ready within the EDRN ecosystem. It is aimed at strengthening the shared infrastructure that allows biomarkers and related early detection tools to move from discovery through structured development and into robust, multicenter validation pathways.Apply for RFA CA 23 031
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394.
- This funding opportunity was created on 2023-03-14.
- Applicants must submit their applications by 2023-05-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $450,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the funding opportunity?
This is an NIH funding opportunity from the National Cancer Institute (NCI): RFA-CA-23-031. It supports a cooperative agreement using the U24 activity code, and clinical trials are not allowed under this solicitation.
What is the main purpose of this award?
The award is intended to establish and operate a Data Management and Coordinating Unit that serves as the coordinating backbone for a precompetitive collaboration focused on liquid biopsy approaches for early cancer assessment.
What does “precompetitive collaboration” mean in this context?
It means the emphasis is on shared resources, standardized practices, and cross-institution coordination that broadly benefits the field rather than supporting proprietary or isolated development efforts.
How does this opportunity relate to the Early Detection Research Network (EDRN)?
The award sits within the mission of NCI’s Early Detection Research Network (EDRN), which is designed to discover, develop, and validate biomarkers and imaging methods for detecting cancers earlier and moving advances toward clinical testing. The solicitation positions EDRN as a mature, multicenter infrastructure that has already completed more than 10 multicenter validation studies.
What kind of work is the funded unit expected to perform?
Based on the description provided, the funded Data Management and Coordinating Unit is expected to support network-scale coordination by managing and harmonizing data flows across participating sites or projects, supporting consistent study operations and communications, and ensuring datasets and related documentation are organized to enable rigorous evaluation, comparison, and eventual validation.
Is this funding meant for a single research project or for network coordination?
This solicitation is framed as support for coordinated, network-scale efforts (shared infrastructure and coordination) rather than isolated or stand-alone research projects.
What funding mechanism is used and what does it imply?
The mechanism is a cooperative agreement (U24). Cooperative agreements typically involve substantial federal involvement, meaning NIH/NCI program staff generally play an active role in oversight and coordination, including guiding goals, milestones, and network integration.
Are clinical trials allowed under this opportunity?
No. The opportunity is listed as “clinical trial not allowed,” meaning applicants may not propose a clinical trial as defined by NIH. The focus should be on coordination, data management, infrastructure, and related non-trial activities that enable or support the broader research enterprise.
What is the maximum award amount listed for this opportunity?
The award ceiling listed is $450,000.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA 93.394.
What is the closing date shown for this solicitation?
The original closing date shown is May 5, 2023, indicating this solicitation was tied to that specific cycle.
What types of organizations are eligible to apply?
Eligibility is broad and includes many U.S.-based organization types, including state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing/Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in that specific classification); for-profit organizations other than small businesses; small businesses; and other eligible entities.
Are minority-serving institutions and community-based organizations included in eligibility?
Yes. The notice explicitly calls out categories often emphasized in NIH funding, including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving institutions, HBCUs, TCCUs, faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
Can foreign organizations apply?
No. The eligibility section states that non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply.
Can a U.S. organization include a non-U.S. (foreign) component in the project?
No. The description states that non-domestic components of U.S. organizations are not eligible to apply and that foreign components (as defined by the NIH Grants Policy Statement) are not allowed. In practical terms, the applicant must be domestic and the project cannot include foreign components under NIH definitions.
What is the overall goal of funding a Data Management and Coordinating Unit for liquid biopsy work?
The overall goal is to strengthen shared infrastructure so multi-site, multi-team liquid biopsy efforts are comparable, reproducible, and ready for rigorous evaluation and multicenter validation within the EDRN ecosystem.
What research area is emphasized by this opportunity?
The focus is on liquid biopsy approaches for early cancer assessment, within an early detection context tied to biomarker discovery, development, and validation pathways.
Browse more opportunities from the same category: Education, Health
Next opportunity: Composting and Food Waste Reduction (CFWR) Pilot Project
Previous opportunity: BJA FY 23 Drug Data Research Center to Combat the Overdose Crisis
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 23 031
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 23 031) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) Apply for PAR 23 122 Funding Number: PAR 23 122 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) Apply for PAR 23 269 Funding Number: PAR 23 269 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA CA 23 028 Funding Number: RFA CA 23 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) Apply for PAR 23 153 Funding Number: PAR 23 153 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) Apply for PAR 23 152 Funding Number: PAR 23 152 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional) Apply for RFA OD 23 015 Funding Number: RFA OD 23 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional) Apply for RFA CA 23 023 Funding Number: RFA CA 23 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) Apply for RFA CA 23 033 Funding Number: RFA CA 23 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 001 Funding Number: RFA DE 24 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) Apply for PAR 23 158 Funding Number: PAR 23 158 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 23 157 Funding Number: PAR 23 157 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Apply for PAR 23 155 Funding Number: PAR 23 155 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed) Apply for RFA DA 24 020 Funding Number: RFA DA 24 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 24 038 Funding Number: RFA DA 24 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 24 021 Funding Number: RFA DA 24 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) Apply for PAR 23 170 Funding Number: PAR 23 170 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional) Apply for RFA DA 24 022 Funding Number: RFA DA 24 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required) Apply for RFA DA 24 015 Funding Number: RFA DA 24 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional) Apply for RFA DA 24 023 Funding Number: RFA DA 24 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA CA 23 029 Funding Number: RFA CA 23 029 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 23 031", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.